Cryo-Cell International, Inc. (CCEL)
Company Info
Highlights
$39.43M
$0.01
487.92
$32.10M
$24.33M
$3.99M
$4.75 - $8.93
$8.50
0.12%
0.45
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in Cryo-Cell International, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
Cryo-Cell International, Inc. (CCEL) returned -28.99% year-to-date (YTD) and -38.02% over the past 12 months. Over the past 10 years, CCEL delivered an annualized return of 11.47%, outperforming the S&P 500 benchmark at 10.43%.
CCEL
-28.99%
-3.32%
-34.99%
-38.02%
-2.26%
11.47%
^GSPC (Benchmark)
-3.70%
13.67%
-5.18%
9.18%
14.14%
10.43%
Monthly Returns
The table below presents the monthly returns of CCEL, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | 5.13% | 4.73% | -19.37% | -17.58% | -2.95% | -28.99% | |||||||
| 2024 | -9.39% | -0.19% | 43.46% | 11.39% | -1.08% | -7.42% | -1.97% | -16.89% | 2.74% | 15.23% | 21.60% | -14.53% | 32.67% |
| 2023 | -4.49% | -5.45% | -20.94% | 106.95% | -22.40% | 25.37% | -6.42% | 5.36% | -12.26% | -0.19% | 1.90% | 7.48% | 35.93% |
| 2022 | -22.16% | -9.97% | -6.15% | -17.96% | -2.08% | -3.75% | -1.36% | 26.63% | -5.72% | -18.20% | -12.42% | -3.20% | -58.46% |
| 2021 | 5.19% | 23.46% | -9.00% | -4.40% | -0.57% | 3.70% | 2.45% | 26.22% | 4.40% | 3.63% | -1.35% | -6.30% | 50.65% |
| 2020 | -1.82% | 2.29% | -11.17% | -1.34% | 17.93% | 12.03% | 3.02% | -1.99% | -4.42% | -16.87% | 12.78% | 2.67% | 8.00% |
| 2019 | -0.00% | -12.67% | 17.40% | -8.97% | 10.00% | 1.62% | 2.11% | -5.76% | 9.56% | -3.03% | -5.63% | -5.56% | -4.93% |
| 2018 | -0.31% | -25.73% | 3.21% | 1.35% | 0.13% | 22.67% | -1.09% | -7.36% | -0.95% | -4.67% | -8.04% | 2.46% | -22.44% |
| 2017 | 3.51% | -7.63% | 6.88% | 11.59% | 7.88% | 7.84% | 7.44% | 3.85% | 0.59% | 10.46% | 7.47% | 19.98% | 112.06% |
| 2016 | -6.25% | 25.00% | -6.67% | -7.14% | -7.69% | 25.00% | 4.27% | 1.02% | -1.52% | 5.40% | 3.66% | 7.29% | 42.50% |
| 2015 | -7.35% | 7.93% | 4.08% | -5.88% | -1.67% | 25.00% | 4.40% | 10.20% | 0.77% | -0.58% | -2.94% | -3.03% | 30.61% |
| 2014 | 5.41% | 16.92% | -3.08% | 0.55% | 10.26% | 6.94% | 3.06% | 9.26% | 12.20% | -10.87% | -5.76% | -11.87% | 32.43% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of CCEL is 17, meaning it’s performing worse than 83% of other stocks on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Cryo-Cell International, Inc. (CCEL) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
Cryo-Cell International, Inc. provided a 9.81% dividend yield over the last twelve months, with an annual payout of $0.50 per share.
| Period | TTM | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Dividend | $0.50 | $0.25 | $0.00 | $0.90 |
Dividend yield | 9.81% | 3.37% | 0.00% | 21.28% |
Monthly Dividends
The table displays the monthly dividend distributions for Cryo-Cell International, Inc.. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | $0.00 | $0.25 | $0.00 | $0.00 | $0.00 | $0.25 | |||||||
| 2024 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.25 | $0.00 | $0.25 |
| 2023 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 2022 | $0.90 | $0.00 | $0.00 | $0.00 | $0.90 |
Dividend Yield & Payout
Dividend Yield
Cryo-Cell International, Inc. has a dividend yield of 9.81%, which means its dividend payment is significantly above the market average.
Payout Ratio
Cryo-Cell International, Inc. has a payout ratio of 3,962.91%, which is above the market average. This might signify the company's strong earnings or financial health. However, it could also hint at a more mature business phase with potentially slower growth.
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Worst Drawdowns
The table below displays the maximum drawdowns of the Cryo-Cell International, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Cryo-Cell International, Inc. was 96.67%, occurring on Nov 18, 2008. Recovery took 2773 trading sessions.
The current Cryo-Cell International, Inc. drawdown is 56.42%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -96.67% | Mar 6, 2000 | 2169 | Nov 18, 2008 | 2773 | Sep 1, 2021 | 4942 |
| -92.13% | Jan 22, 1997 | 403 | Oct 8, 1998 | 287 | Nov 30, 1999 | 690 |
| -76.11% | Sep 3, 2021 | 391 | Mar 28, 2023 | — | — | — |
| -28.91% | Dec 7, 1999 | 49 | Feb 15, 2000 | 10 | Mar 1, 2000 | 59 |
Volatility
Volatility Chart
The current Cryo-Cell International, Inc. volatility is 16.66%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Cryo-Cell International, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Earnings Per Share
The chart presents the Earnings Per Share (EPS) performance of Cryo-Cell International, Inc., comparing actual results with analytics estimates. In the past quarter, the company did not meet analyst expectations for EPS, resulting in a surprise of -2,403.0%.
Valuation
The Valuation section provides an overview of how Cryo-Cell International, Inc. is priced in the market compared to other companies in the Medical Care Facilities industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PE Ratio
The chart displays the Price-to-Earnings (P/E) ratio for CCEL, comparing it with other companies in the Medical Care Facilities industry. Currently, CCEL has a P/E ratio of 487.9. This P/E ratio is significantly higher than those of industry peers. This could indicate that the stock is overvalued or that investors expect strong future growth.
PEG Ratio
The chart shows the Price/Earnings to Growth (PEG) ratio for CCEL compared to other companies in the Medical Care Facilities industry. CCEL currently has a PEG ratio of 0.0. This PEG ratio is low compared to industry peers, which could indicate the stock is undervalued relative to its expected growth.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for CCEL relative to other companies in the Medical Care Facilities industry. Currently, CCEL has a P/S ratio of 1.2. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for CCEL in comparison with other companies in the Medical Care Facilities industry. Currently, CCEL has a P/B value of 9.7. This P/B ratio is higher than most companies in the industry. It may suggest the stock is overvalued or that investors expect the company to generate high returns on its assets.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |